Featured Research

from universities, journals, and other organizations

MA healthcare reform does not have early impact on disparities in cardiovascular care

Date:
June 19, 2014
Source:
Brigham and Women's Hospital
Summary:
Healthcare reform in Massachusetts has not yet impacted the likelihood of receiving coronary interventions by gender, race/ethnicity or socioeconomic status, a new research report concludes.

New research by the Brigham and Women's Hospital, in partnership with Howard University College of Medicine, explores the effect of healthcare reform in Massachusetts on coronary intervention and mortality in adults by race/ethnicity, gender and the level of education in the neighborhood where the patient resides.

Published in the June 17, 2014, issue of Circulation, the journal of the American Heart Association, these findings indicate that healthcare reform in Massachusetts has not yet impacted the likelihood of receiving coronary interventions by gender, race/ethnicity or socioeconomic status.

"Despite healthcare reform, which mandates individual health insurance coverage in Massachusetts, disparities persist in an important area of cardiac care, such as performance of potentially life-saving coronary interventions in certain vulnerable groups, including blacks, Hispanics and women," said the study's lead author, Michelle A. Albert, M.D., M.P.H., Vivian Beaumont Allen Endowed Professor and Chief, Cardiovascular Medicine and Research at Howard University College of Medicine.

Specifically, researchers report that among patients hospitalized at non-federal acute care hospitals:

  • Blacks and Hispanics were 30 percent and 16 percent respectively less likely than whites to receive coronary revascularization post-healthcare reform. These statistics are consistent with the data available before reform was enacted.
  • Those living in neighborhoods with higher educational attainment and Asians were more likely to undergo revascularization than patients from relatively lower neighborhood education attainment environments and whites post-reform.
  • Women were 50 percent less likely to undergo revascularization than men.
  • Privately insured patients were more likely to receive revascularization both before and after statewide healthcare reform was enacted.
  • Researchers report no differences in one-year mortality rates in any of the groups.

"Although, there were no differences in one-year mortality in the subgroups assessed, our results suggest the need to better understand factors that contribute to observed differences since health-care equity is critical to long-term quality and quantity of life," said Albert, who began this research work at Brigham and Women's Hospital in 2010 when she was a physician-scientist in the Cardiovascular Division. "Findings in Massachusetts where near-uniform health insurance coverage exists could provide important insight into translation of reform at the national level."

Researchers emphasize that besides insurance coverage, there are multiple other dynamics that potentially contribute to differences in odds of receiving coronary procedures based on socio-demographic characteristics. Influencing factors include differences in heart disease risk factor burden, other financial and social factors, behavior, chronic psychological stress, strained interactions with the healthcare system, access to appropriate health care, bias, and differential severity of heart disease at the time of presentation to the healthcare system.


Story Source:

The above story is based on materials provided by Brigham and Women's Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. A. Albert, J. Z. Ayanian, T. S. Silbaugh, A. Lovett, F. Resnic, A. Jacobs, S.-L. T. Normand. Early Results of Massachusetts Healthcare Reform on Racial, Ethnic, and Socioeconomic Disparities in Cardiovascular Care. Circulation, 2014; 129 (24): 2528 DOI: 10.1161/CIRCULATIONAHA.113.005231

Cite This Page:

Brigham and Women's Hospital. "MA healthcare reform does not have early impact on disparities in cardiovascular care." ScienceDaily. ScienceDaily, 19 June 2014. <www.sciencedaily.com/releases/2014/06/140619111527.htm>.
Brigham and Women's Hospital. (2014, June 19). MA healthcare reform does not have early impact on disparities in cardiovascular care. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/06/140619111527.htm
Brigham and Women's Hospital. "MA healthcare reform does not have early impact on disparities in cardiovascular care." ScienceDaily. www.sciencedaily.com/releases/2014/06/140619111527.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins